Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Neoadjuvant chemoradiation does not improve outcomes for patients undergoing resection for upper rectal cancer: A US Rectal Cancer Consortium analysis.
Authors
Caroline Medin
Emory University, Atlanta, GA;
Caroline Medin , Adriana C. Gamboa , Emilie Warren , Scott E. Regenbogen , Samantha Hendren , Jennifer Holder-Murray , Matthew Kalady , Aslam Ejaz , Alexander Hawkins , Matthew Silviera , Shishir K. Maithel , Glen C. Balch
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 143)
DOI
10.1200/JCO.2023.41.4_suppl.143
Abstract #
143
Poster Bd #
H2
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Timing of surgery following neoadjuvant chemoradiation in rectal cancer: A retrospective analysis from an academic medical center.
First Author: Justin Chau
Poster
2023 ASCO Annual Meeting
A 19-protein signature to predict outcomes in a cohort of stage II and III CRC.
First Author: Rosemary Habib
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Incomplete preoperative staging results in suboptimal treatment in rectal cancer patients: A population-based study.
First Author: Sunil Patel
Poster
2019 Gastrointestinal Cancers Symposium
Predictors of survival in rectal squamous cell carcinoma: An analysis from the National Cancer Database (NCDB).
First Author: Sri Harsha Tella